Xilio Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $137.5M | $55.3M | $44.7M | $120.4M | $198.1M | $19.2M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $145.0M | $60.2M | $48.1M | $124.5M | $202.5M | $20.6M |
| Property, Plant & Equipment | $3.9M | $4.5M | $5.9M | $7.3M | $7.6M | $7.4M |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $154.7M | $71.1M | $60.9M | $139.2M | $218.1M | $36.3M |
| Liabilities | ||||||
| Accounts Payable | $3.2M | $2.6M | $1.1M | $3.1M | $3.1M | $5.4M |
| Total Current Liabilities | $56.3M | $27.3M | $16.0M | $21.1M | $12.8M | $22.2M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $119.4M | $53.5M | $24.1M | $33.5M | $32.6M | $41.6M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-418.8M | $-383.8M | $-325.5M | $-249.1M | $-160.9M | $-85.1M |
| Total Stockholders' Equity | $35.3M | $17.6M | $36.8M | $105.6M | $185.4M | $-83.3M |